Literature DB >> 33217007

Finger drop sign as a new variant of acute motor axonal neuropathy.

Byeol-A Yoon1,2, Dong-Ho Ha3, Hwan Tae Park2,4, Susumu Kusunoki5, Motoi Kuwahara5, Jong Hwa Lee6, Jong Seok Bae7, Jong Kuk Kim1,2.   

Abstract

We propose the finger drop sign as a new clinical variant of acute motor axonal neuropathy (AMAN) defined by immunological and radiological evidence. We identified eight consecutive patients who had AMAN. All of them developed prominent involvement of the finger extensors. We performed magnetic resonance imaging (MRI) of the extremity muscles and serological assays for antiganglioside antibodies and Campylobacter jejuni. Patients with AMAN showed characteristic and a markedly sustained weakness of the finger extensors with a distinctive pattern of the finger drop sign. Limb MRI revealed unevenly distributed abnormal signals in the muscles mainly innervated by the posterior interosseous nerve. All tested patients showed positivity for immunoglobulin G antibody against ganglioside complex of GM1 and phosphatidic acid. A pathophysiological understanding of this unique syndrome can provide further insight into antiganglioside-antibody-mediated axonal injury in Guillain-Barré syndrome.
© 2020 The Authors. Muscle & Nerve published by Wiley Periodicals LLC.

Entities:  

Keywords:  Guillain-Barré syndrome; acute motor axonal neuropathy; antiganglioside antibodies; magnetic resonance imaging; posterior interosseous nerve

Mesh:

Substances:

Year:  2020        PMID: 33217007     DOI: 10.1002/mus.27126

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.

Authors:  Minsung Kang; Hung Youl Seok
Journal:  J Korean Med Sci       Date:  2022-05-23       Impact factor: 5.354

2.  Letter to the Editor: Finger Extensor Weakness Is Not a Novel Clinical Feature of SARS-CoV-2 Associated Guillain-Barre Syndrome.

Authors:  Josef Finsterer
Journal:  J Korean Med Sci       Date:  2022-07-11       Impact factor: 5.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.